FHIR © HL7.org  |  Server Home  |  XIG Home  |  XIG Stats  |  Server Source  |  FHIR  

FHIR IG Statistics: FHIR Resources

Resources - All Kinds, Authority Hl7

42,405 resources

Type: Text:

By Version

By Realm

 

Start Prev Rows 35800 - 36000 Next

PackageVersionIdentityName/TitleStatusFMMWGDateRealm
hl7.fhir.us.davinci-pctR4ValueSet/PCTGFETypeOfBillVSPCT GFE NUBC Uniform Billing (UB-04) Type of Bill Value Settrial-usefm2025-08us
signal.core.r4R4ValueSet/provider-taxonomyProvider Taxonomy Codesdraftvocab2023-03us
fhir.cdc.opioid-cds-r4R4ValueSet/oncology-specialty-designationsOncology specialty designations (NUCC)active2023-05us
hl7.fhir.us.vdorR4ValueSet/vdor-gun-owner-codes-vsVDOR Coding Manual Gun Owner Codes Value Setinformativepher2025-06us
hl7.fhir.us.registry-protocolsR4ValueSet/NewYorkHeartAssociationAnswersNew York Heart Association OA Answer Listactivecic2023-11us
hl7.org.nz.fhir.ig.formularyR4BValueSet/nzf-description-typesNZMT Description typesactive2025-08nz
nictiz.fhir.nl.r4.zib2020R4ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.14.1.5--20200901000000VerrichtingTypeNZaCodelijstactivenl
nictiz.fhir.nl.r4.zib2020R4ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.20.4.1--20200901000000NaamgebruikCodelijstactivenl
nictiz.fhir.nl.stu3.zib2017R3ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.20.4.1--20171231000000NaamgebruikCodelijstactivenl
hl7.terminologyR5ValueSet/v3-NailRouteNailRouteactive2014-03uv
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1021.121Federal Administrative Sexactive2025-02us
hl7.terminologyR5ValueSet/v2-0396hl7VS-codingSystemactive2019-12uv
hl7.terminologyR5ValueSet/v3-NasalRouteNasalRouteactive2014-03uv
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1032.292Non pharmacologic treatments for chronic pain NCIactive2024-06us
hl7.terminologyR5ValueSet/v3-EntityClassFoodEntityClassFoodactive2014-03uv
hl7.terminologyR5ValueSet/v3-NebulizationNebulizationactive2014-03uv
nictiz.fhir.nl.r4.zib2020R4ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.13.1.3--20200901000000TestCodeLOINCCodelijstactivenl
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1078.581PIM_Avandametactive2023-08us
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1032.26Nonopioid pain medicationsactive2023-03us
us.nlm.vsacR4ValueSet/2.16.840.1.113883.11.20.9.59DIRSectionTypeCodesactive2024-06us
hl7.eu.fhir.idea4rcR4ValueSet/new-cancer-topography-i4rcNew Cancer Topographyactive2025-07eu
hl7.org.nz.fhir.ig.formularyR4BValueSet/nzf-document-typeNZF Document Typeactive2025-08nz
hl7.org.nz.fhir.ig.formularyR4BValueSet/nzmt-type-codeNzmt typeactive2025-08nz
fhir.org.nz.ig.baseR4ValueSet/coverage-typeCoverage Typeactive2025-06us
fhir.org.nz.ig.baseR4ValueSet/coverage-categoryCoverage Categoryactive2025-06us
fhir.org.nz.ig.baseR4ValueSet/iwiIwiactive2025-06us
ee.fhir.terminologyR5ValueSet/national-identifier-requirementNational identifier requirementactive2025-06ee
hl7.fhir.cl.minsal.eisR4ValueSet/VSNivelAtencionNivelAtencionactive2023-01cl
hl7.fhir.cl.minsal.eisR4ValueSet/VSNivelComplejidadNivelComplejidadactive2023-01cl
fhir.giisR4ValueSet/NonVaccinationReasonVSNon vaccination reasondraft2025-07us
hl7.fhir.us.hsdsR4ValueSet/NonIndividualSpecialtiesNon-Individual Specialtiestrial-use2hss2023-10us
hl7.fhir.us.directory-queryR4ValueSet/NonIndividualSpecialtiesVSNon-Individual Specialtiesactive2022-12us
hl7.fhir.us.davinci-pdex-plan-netR4ValueSet/NonIndividualSpecialtiesVSNon-Individual Specialtiestrial-usefm2025-02us
hl7.fhir.us.directory-queryR4ValueSet/NonIndividualSpecialtyAndDegreeLicenseCertificateVSNon-Individual Specialties, Degrees, Licenses, and Certificates Value Setactive2022-12us
hl7.fhir.us.davinci-pdex-plan-netR4ValueSet/NonIndividualSpecialtyAndDegreeLicenseCertificateVSNon-Individual Specialties, Degrees, Licenses, and Certificates VStrial-usefm2025-02us
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1046.279Triageactive2025-02us
hl7.fhir.us.registry-protocolsR4ValueSet/NonSustainedVentricularTachycardiaTypeNon-Sustained Ventricular Tachycardia Typeactivecic2023-11us
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1213.114NSAIDs Ingredients and Risk of GI Bleedingactive2023-12us
openehr.baseR5ValueSet/normal-statusesNormal statusesinformative3fhir2024-04uv
hl7.fhir.us.mcodeR4ValueSet/mcode-normalization-basis-vsNormalization Basis Value Setactivecic2025-02us
hl7.eu.fhir.pcspR4ValueSet/vs-naunk-eu-pcspNot Applicable|Unknowndraft2025-08eu
hl7.eu.fhir.idea4rcR4ValueSet/vs-npunk-eu-i4rcNot Performed|Unknowndraft2025-07eu
hl7.eu.fhir.pcspR4ValueSet/vs-npunk-eu-pcspNot Performed|Unknowndraft2025-08eu
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1247.208Social Determinants of Health Screening Assessments Answersactive2024-12us
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1247.207Social Determinants of Health Screening Assessments Questionsactive2024-12us
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1247.206Social Determinants of Health Screening Assessments And Questionsactive2024-12us
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1247.126Social Determinants of Health Screening Assessmentsactive2023-12us
hl7.fhir.us.breast-radiologyR4ValueSet/NotPreviouslySeenVSNotPreviouslySeen ValueSetactive2022-12us
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1222.815Drugs of Abuse Screen in Urineactive2023-07us
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1222.898Forearm X Rayactive2024-07us
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1078.455Metabolic acidosis I10active2023-07us
hl7.terminologyR5ValueSet/v2-0309hl7VS-coverageTypeactive2019-12uv
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1115.15Upon Death Preferencesactive2025-04us
openehr.baseR5ValueSet/null-flavoursNull Flavoursinformative3fhir2024-08uv
hl7.fhir.us.davinci-crdR4ValueSet/cmslocationcodesCMS Location Codes Value Settrial-use4fm2025-08us
nictiz.fhir.nl.r4.zib2020R4ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.20.6.2--20200901000000NummerSoortCodelijstactivenl
nictiz.fhir.nl.stu3.zib2017R3ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.20.6.2--20171231000000NummerSoortCodelijstactivenl
hl7.terminologyR5ValueSet/nutrition-intake-categoryNutrition intake category codesdraftoo2020-02uv
hl7.fhir.uv.eyecareR4ValueSet/observation-oct-maculaOCT Macula Observable Entities ValueSetactive2019-05uv
hl7.fhir.uv.eyecareR4ValueSet/observation-oct-rnflOCT RNFL Observable Entities ValueSetactive2019-05uv
nictiz.fhir.nl.stu3.zib2017R3ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.4.26.1--20171231000000StatusNaamOMAHACodelijstactivenl
nictiz.fhir.nl.stu3.zib2017R3ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.4.26.5--20171231000000StatusWaardeOMAHACodelijstactivenl
nictiz.fhir.nl.r4.zib2020R4ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.4.26.1--20200901000000StatusNaamOMAHACodelijstretirednl
nictiz.fhir.nl.r4.zib2020R4ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.4.26.5--20200901000000StatusWaardeOMAHACodelijstretirednl
us.nlm.vsacR4ValueSet/1.3.6.1.4.1.6997.4.1.2.234.13.13.1.15.1.999.1Selected non pharmaceutical therapies for moderate to severe chronic painactive2015-08us
us.nlm.vsacR4ValueSet/1.3.6.1.4.1.6997.4.1.2.234.13.13.1.16.1.11.1.999.3selected muscle relaxants for pain controlactive2015-08us
us.nlm.vsacR4ValueSet/1.3.6.1.4.1.6997.4.1.2.234.13.13.1.16.1.12.1.999.3Selected topical agents for pain controlactive2015-08us
us.nlm.vsacR4ValueSet/1.3.6.1.4.1.6997.4.1.2.234.13.13.1.17.1.1.999.2selected non opioids for moderate to severe painactive2015-08us
us.nlm.vsacR4ValueSet/1.3.6.1.4.1.6997.4.1.2.234.13.13.1.17.1.11.1.999.2Selected opioids for moderate to severe painactive2015-08us
us.nlm.vsacR4ValueSet/1.3.6.1.4.1.6997.4.1.2.234.15.2.1.1.999.1Selected urine drug screens for opioids indicating testing is completeactive2015-08us
us.nlm.vsacR4ValueSet/1.3.6.1.4.1.6997.4.1.2.234.999.2Selected urine screening for patients receiving opioid therapyactive2015-08us
us.nlm.vsacR4ValueSet/1.3.6.1.4.1.6997.4.1.2.234.999.3.1Opioids used for pain controlactive2015-08us
us.nlm.vsacR4ValueSet/1.3.6.1.4.1.6997.4.1.2.234.13.13.1.16.1.1.999.3selected first line medications for pain controlactive2015-08us
us.nlm.vsacR4ValueSet/1.3.6.1.4.1.6997.4.1.2.234.15.7.1.1.11.1.999.1selected follow up visit intervals for opioid monitoringactive2015-08us
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.3157.1019Diseases of Urinary Systemactive2020-07us
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.3157.1301Surgery Integumentary System Breastactive2020-07us
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.3157.1302Surgery Respiratory System Accessory Sinusesactive2020-07us
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.3157.1303Surgery Respiratory System Larynxactive2020-07us
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.3157.1304Surgery Respiratory System Trachea and Bronchiactive2020-07us
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.3157.1305Surgery Respiratory System Lungs and Pleuraactive2020-07us
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.3157.13064Surgery Digestive System Esophagusactive2020-06us
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.3157.1307Surgery Digestive System Intestines (Except Rectum)active2017-05us
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.3157.1308Surgery Digestive System Rectumactive2019-08us
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.3157.1309Surgery Digestive System Anusactive2020-07us
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.3157.1310Surgery Digestive System Biliary Tractactive2020-07us
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.3157.1311Surgery Digestive System Abdomen Peritoneum Omentumactive2020-07us
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.3157.1312Surgery Digestive System Kidneyactive2020-07us
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.3157.13133Surgery Digestive System Ureteractive2017-05us
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.3157.1314Surgery Digestive System Bladderactive2020-07us
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.3157.1315Surgery Female Genital System Cervix Uteriactive2020-07us
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.3157.1316Surgery Female Genital System Corpus Uteriactive2020-07us
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.3157.1317Surgery Female Genital System Oviduct Ovaryactive2020-07us
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.3157.1318Surgery Eye and Ocular Adnexa Anterior Segmentactive2020-07us
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.3157.13193Other Surgeriesactive2017-05us
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.3157.13202SPECT MPIactive2020-06us
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.3157.13213Stress Echocardiographyactive2017-05us
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.3157.13222Stress MRIactive2020-06us
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.3157.1323CCTAactive2020-07us
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.3157.1329Diabetes Mellitusactive2020-07us
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.3157.1330Renal insufficiencyactive2020-07us
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.3157.1331Stroke transient ischemic attackactive2020-07us
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.3157.1332Prior heart failureactive2020-07us
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.3157.1333Ischemic heart diseaseactive2020-07us
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.3157.1804Claim(s) for evaluation and management > 28 days and <60 days preceding the lumbar spine MRIactive2020-08us
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.3157.18143Patients with lumbar spine surgery in the 90 days prior to MRIactive2020-08us
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.3157.1832Canceractive2020-07us
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.3157.1838Neoplastic abnormalitiesactive2020-07us
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.3157.1839Treatment fields for radiation therapyactive2020-07us
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.3157.1842Postoperative fluid collections and soft tissue changesactive2020-07us
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.3157.1847Unspecified Immune Deficienciesactive2020-07us
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.3157.1833Congenital spine and spinal cord malformationsactive2020-07us
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.3157.1834Inflammatory and autoimmune disordersactive2020-07us
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.3157.1835Infectious conditionsactive2020-07us
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.3157.1836Spinal vascular malformations and/or the cause of occult subarachnoid hemorrhageactive2020-07us
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.3157.1837Spinal cord infarctionactive2020-07us
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.3157.1840Spinal abnormalities associated with scoliosisactive2020-07us
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.3157.1841Syringohydromyeliaactive2020-08us
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.3157.1844IV Drug Abuseactive2022-04us
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.3157.1845Neurological Impairmentactive2020-07us
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.3157.1846Human Immunodeficiency Virusactive2020-07us
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.3157.1843Traumaactive2020-07us
de.basisprofil.r4R4ValueSet/ops-vsOPS ValueSetactive2025-06
hl7.fhir.uv.extensionsR5ValueSet/obligationObligation Codes ValueSettrial-use1fhir2025-08uv
hl7.fhir.cl.minsal.r2boR4ValueSet/r2bo-observaciones-biopsia-VSSet de Valores para Observaciones Biopsiainformativeoo2025-08cl
hl7.fhir.au.baseR4ValueSet/au-observation-category-extendedObservation Category Codes - AU Extendedtrial-use02025-06au
hl7.terminologyR5ValueSet/observation-categoryObservation Category Codesactive1oo2024-04uv
signal.core.r4R4ValueSet/observation-categoryObservation Category Codesdraft1oo2019-10us
fhir.outburn.co.ilR4ValueSet/vs-observation-interpretationObservation Interpretationdraftus
ee.hl7.fhir.base.r5R5ValueSet/ee-observation-categoryObservation Categorydraft2023-08ee
ee.fhir.terminologyR5ValueSet/observation-categoryObservation Categoryactive2025-06ee
ca.on.oh-olisR4ValueSet/olis-ObservationCategoryCodesObservationCategoryCodesactive
hl7.fhir.us.vdorR4ValueSet/vdor-toxicology-summary-tests-vsVDOR Toxicology Summary Tests Value Setinformativepher2025-06us
hl7.terminologyR5ValueSet/v3-ObservationInterpretationExpectationObservationInterpretationExpectationactive2019-03uv
hl7.fhir.uv.pocdR4ValueSet/observation-interpretationObservation interpretation codesdraft2019-09uv
hl7.terminologyR5ValueSet/v3-PopulationInclusionObservationTypePopulationInclusionObservationTypeactive2014-03uv
hl7.terminologyR5ValueSet/v3-CompositeMeasureScoringCompositeMeasureScoringactivecqi2019-03uv
hl7.terminologyR5ValueSet/measure-improvement-notationMeasureImprovementNotationactive2cqi2024-04uv
hl7.terminologyR5ValueSet/v3-ObservationPopulationInclusionObservationPopulationInclusionretired2014-03uv
hl7.terminologyR5ValueSet/v3-KnowledgeSubjectObservationValueKnowledgeSubjectObservationValueactive2010-03uv
hl7.terminologyR5ValueSet/v3-KnowledgeSubtopicObservationValueKnowledgeSubtopicObservationValueactive2010-03uv
hl7.terminologyR5ValueSet/v3-SecurityObservationValueSecurityObservationValueactive2014-03uv
hl7.terminologyR5ValueSet/v3-AgeGroupObservationValueAgeGroupObservationValueactive2010-03uv
hl7.terminologyR5ValueSet/v3-ObservationMeasureTypeObservationMeasureTypeactive2014-08uv
uk.nhsdigital.r4.testR4ValueSet/8fbd7c75-858b-4932-87dc-a5e8d29e40c1ObservationCategorydraft2022-08
de.netzwerk-universitaetsmedizin.ebm-cpgR5ValueSet/vs-observationsObservationsdraft2024-05uv
hl7.fhir.us.breast-radiologyR4ValueSet/ObservedChangesVSObservedChanges ValueSetactive2022-12us
hl7.fhir.cz.terminologyR5ValueSet/nrzp-povolani-vsOccupation of healthcare practitioner (CZ)trial-use22024-01cz
hl7.eu.fhir.idea4rcR4ValueSet/occurrence-other-cancer-i4rcOccurrence of other canceractive2025-07eu
ca.on.oh.mha-pdsR4ValueSet/ValueSet.ca-on-mha-PreferredOfficialLanguagePreferred Official Languageactive2022-08ca
hl7.fhir.be.pssR4ValueSet/OncologyPatientCodesOncologyPatient Codesactive2025-07be
hl7.terminologyR5ValueSet/v3-CalendarCycleOneLetterCalendarCycleOneLetteractive2014-03uv
hl7.terminologyR5ValueSet/v3-ObservationInterpretationObservationInterpretationactive2014-03uv
hl7.terminologyR5ValueSet/v3-SiblingSiblingactive2014-03uv
hl7.terminologyR5ValueSet/v3-xParticipationAuthorPerformerx_ParticipationAuthorPerformeractive2014-03uv
hl7.terminologyR5ValueSet/v3-xParticipationVrfRespSprfWitx_ParticipationVrfRespSprfWitactive2014-03uv
hl7.terminologyR5ValueSet/v3-ParticipationEscortParticipationEscortactive2014-03uv
hl7.terminologyR5ValueSet/v3-ParticipationWitnessParticipationWitnessactive2014-03uv
nictiz.fhir.nl.r4.zib2020R4ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.4.32.3--20200901000000OntwikkelingMotoriekCodelijstactivenl
nictiz.fhir.nl.stu3.zib2017R3ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.4.32.3--20171231000000OntwikkelingMotoriekCodelijstactivenl
nictiz.fhir.nl.r4.zib2020R4ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.4.32.4--20200901000000OntwikkelingSociaalCodelijstactivenl
nictiz.fhir.nl.stu3.zib2017R3ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.4.32.4--20171231000000OntwikkelingSociaalCodelijstactivenl
nictiz.fhir.nl.r4.zib2020R4ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.4.32.5--20200901000000OntwikkelingTaalCodelijstactivenl
nictiz.fhir.nl.stu3.zib2017R3ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.4.32.5--20171231000000OntwikkelingTaalCodelijstactivenl
nictiz.fhir.nl.r4.zib2020R4ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.4.32.6--20200901000000OntwikkelingVerstandelijkCodelijstactivenl
nictiz.fhir.nl.stu3.zib2017R3ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.4.32.6--20171231000000OntwikkelingVerstandelijkCodelijstactivenl
basisprofil.deR3ValueSet/ValueSet-dimdi-opsopsdraft2017-09
hl7.terminologyR5ValueSet/v3-OphthalmicRouteOphthalmicRouteactive2014-03uv
fhir.cdc.opioid-cds-r4R4ValueSet/synthetic-opioid-medicationsSynthetic opioid medicationsactive2023-05us
hl7.terminologyR5ValueSet/v3-OralRouteOralRouteactive2014-03uv
hl7.fhir.us.carin-bbR4ValueSet/OralBodySiteOral Body Site Value Settrial-usefm2025-02us
hl7.terminologyR5ValueSet/v3-OtherActionTakenManagementCodeOtherActionTakenManagementCodeactive2014-03uv
hl7.fhir.us.haiR4ValueSet/nhsn-pathogen-rankingNHSNPathogenRankingactive2023-09us
nictiz.fhir.nl.r4.zib2020R4ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.17.2.3--20200901000000OrganisatieTypeCodelijstactivenl
nictiz.fhir.nl.stu3.zib2017R3ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.17.2.3--20171231000000OrganisatieTypeCodelijstactivenl
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1237.13SNOMED Organism from LOINC Answer Listactive2024-01us
hl7.fhir.cr.coreR5ValueSet/expedition-organization-patient-identifierOrganización que expiden tipos de identificación para el pacientedraft0cgp2025-03cr
ForgePatientChart.0830R4ValueSet/telus-organizationaffiliation-partnerTELUS ValueSet - Organization Affiliation partnerdraft2020-11
ee.hl7.fhir.base.r5R5ValueSet/ee-organization-typeOrganization Typesdraft2023-08ee
ee.fhir.terminologyR5ValueSet/organization-typeOrganization Typesactive2025-06ee
hl7.fhir.fr.coreR4ValueSet/fr-core-vs-organization-uf-activity-fieldFR Core ValueSet Organization UF activity fieldinformative1fhir2024-09fr
ca.on.ppr.r4R4ValueSet/OrganizationOperationalStatus-providerOperationalStatusdraft
hl7.fhir.fr.coreR4ValueSet/fr-core-vs-organization-typeFR Core ValueSet Organization typeactive2024-09fr
hl7.fhir.sami.coreR4ValueSet/Human_sex_orientationOrientação sexualactive2022-02sami
hl7.fhir.cl.minsal.nidR4ValueSet/VSOrigenDiscapacidadOrigen Discapacidadactive2023-01cl
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1010.8Vaccine Clinical Drugactive2024-06us
hl7.terminologyR5ValueSet/v3-OromucosalRouteOromucosalRouteactive2014-03uv
hl7.terminologyR5ValueSet/v3-OropharyngealRouteOropharyngealRouteactive2014-03uv
hl7.fhir.be.pssR4ValueSet/OtherCodesOther Codesactive2025-07be
hl7.eu.fhir.pcspR4ValueSet/otherInfos-condition-vsOther Infors Conditiondraft2025-08eu
hl7.eu.fhir.idea4rcR4ValueSet/other-treatment-procedure-type-eu-i4rcOther Treatment Procedure Typedraft2025-07eu
fhir.giisR4ValueSet/OtherVaccineVSOther Vaccine codesdraft2025-07us
hl7.fhir.nz.ccaR4ValueSet/sact-plan-definition-status-codePlanDefinition additional statusactive2020-11nz
hl7.eu.fhir.pcspR4ValueSet/vs-othUnkTxt-eu-pcspOther/Unknown/Textdraft2025-08eu
hl7.terminologyR5ValueSet/v3-OticRouteOticRouteactive2014-03uv
hl7.fhir.cl.minsal.eisR4ValueSet/VSOtroTipoEstabAsistencialesOtroTipoEstabAsistencialesactive2023-01cl
us.nlm.vsacR4ValueSet/2.16.840.1.113883.11.20.9.86Pregnancy Outcomeactive2024-06us
hl7.terminologyR5ValueSet/adverse-event-categoryAdverseEventCategoryactive0pc2024-04uv
hl7.terminologyR5ValueSet/adverse-event-seriousnessAdverseEventSeriousnessactive1pc2024-04uv
hl7.org.nz.fhir.ig.formularyR4BValueSet/nzf-funding-typePHARMAC funding typeactive2025-08nz
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1196.4436Gentamicin medicationsactive2024-05us